Gayle M. Vranic, MD

Gayle M. Vranic, MD

Gayle Vranic

Assistant Professor of Medicine

MD: University of North Carolina
Residency: Vanderbilt University
Fellowships: Vanderbilt University, Clinical Nephrology, and University of Virginia, Transplant Nephrology.
Certification: Internal Medicine, Nephrology

434-971-8888 | Fax 434-924-5848 | gmv2e@virginia.edu

My primary responsibility is for the care of patients at the University of Virginia Health System.

Research Interests

Examining racial and geographic barriers to renal transplantation, impact of multiple organ transplants on access to transplant, and the role of pre-sensitization in antibody mediated rejection in renal transplant recipients.


References
PubMed Search for articles by faculty member »

Birdwell KA, Grady B, Choi L, Xu H, Bian A, Denny JC, Jiang M, Vranic G, Basford M, Cowan JD, Richardson DM, Robinson MP, Ikizler TA, Ritchie MD, Stein CM, Haas DW. The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients. Pharmacogenet Genomics 2012;22:32-42.

Ambler, CA, Schmunk (Vranic), GM, and Bautch, VL. Stem cell-derived endothelial cells/progenitors migrate and pattern in the embryo using the VEGF signaling pathway. Dev Biol 2003;257:205-19.